Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 131

1.

Detection of Klebsiella. Pneumoniae Infection with an Antisense Oligomer Against its Ribosomal RNA.

Chen L, Cheng D, Liu G, Dou S, Wang Y, Liu X, Liu Y, Rusckowski M.

Mol Imaging Biol. 2016 Aug;18(4):527-34. doi: 10.1007/s11307-015-0927-4.

PMID:
26832678
2.

Targeted scVEGF/(177)Lu radiopharmaceutical inhibits growth of metastases and can be effectively combined with chemotherapy.

Rusckowski M, Wang Y, Blankenberg FG, Levashova Z, Backer MV, Backer JM.

EJNMMI Res. 2016 Dec;6(1):4. doi: 10.1186/s13550-016-0163-1. Epub 2016 Jan 16.

3.

Novel DNA Polymer for Amplification Pretargeting.

Li X, Huang Q, Xiao J, Liu G, Dou S, Rusckowski M, Shi H, Liu Y, Cheng D.

ACS Med Chem Lett. 2015 Jul 27;6(9):972-6. doi: 10.1021/acsmedchemlett.5b00265. eCollection 2015 Sep 10.

4.

Phenoxide-Bridged Zinc(II)-Bis(dipicolylamine) Probes for Molecular Imaging of Cell Death.

Clear KJ, Harmatys KM, Rice DR, Wolter WR, Suckow MA, Wang Y, Rusckowski M, Smith BD.

Bioconjug Chem. 2016 Feb 17;27(2):363-75. doi: 10.1021/acs.bioconjchem.5b00447. Epub 2015 Sep 11.

5.

Evaluation of [¹¹¹In]-labeled zinc-dipicolylamine tracers for SPECT imaging of bacterial infection.

Rice DR, Plaunt AJ, Turkyilmaz S, Smith M, Wang Y, Rusckowski M, Smith BD.

Mol Imaging Biol. 2015 Apr;17(2):204-13. doi: 10.1007/s11307-014-0758-8.

6.

Differentiation between temporary and real non-clearability of biotinylated IgG antibody by avidin in mice.

Dou S, Virostko J, Rusckowski M, Greiner DL, Powers AC, Liu G.

Front Pharmacol. 2014 Jul 24;5:172. doi: 10.3389/fphar.2014.00172. eCollection 2014.

7.

Comparison between two labeled agents in mice using a coinjection-ratio approach in contrast to a conventional group approach.

Dou S, Wang Y, Barton B, Chen L, Rusckowski M, Shultz LD, Greiner DL, Liu G.

Nucl Med Biol. 2014 Jan;41(1):127-31. doi: 10.1016/j.nucmedbio.2013.10.001. Epub 2013 Oct 9.

8.

(99m)Tc-MORF oligomers specific for bacterial ribosomal RNA as potential specific infection imaging agents.

Chen L, Wang Y, Cheng D, Liu X, Dou S, Liu G, Hnatowich DJ, Rusckowski M.

Bioorg Med Chem. 2013 Nov 1;21(21):6523-30. doi: 10.1016/j.bmc.2013.08.034. Epub 2013 Aug 28.

9.

Reply to Regarding the mechanism of action of a proposed peptide agonist of the bone morphogenetic protein receptor activin-like kinase 3.

Sugimoto H, LeBleu VS, Bosukonda D, Keck P, Taduri G, Bechtel W, Okada H, Carlson W, Bey P, Rusckowski M, Tampe B, Tampe D, Kanasaki K, Zeisberg M, Kalluri R.

Nat Med. 2013 Jul;19(7):810-1. doi: 10.1038/nm.3081. No abstract available.

PMID:
23836214
10.

Intraperitoneal injection is not always a suitable alternative to intravenous injection for radiotherapy.

Dou S, Smith M, Wang Y, Rusckowski M, Liu G.

Cancer Biother Radiopharm. 2013 May;28(4):335-42. doi: 10.1089/cbr.2012.1351. Epub 2013 Mar 7.

11.

Detection of Aspergillus fumigatus pulmonary fungal infections in mice with (99m)Tc-labeled MORF oligomers targeting ribosomal RNA.

Wang Y, Chen L, Liu X, Cheng D, Liu G, Liu Y, Dou S, Hnatowich DJ, Rusckowski M.

Nucl Med Biol. 2013 Jan;40(1):89-96. doi: 10.1016/j.nucmedbio.2012.10.001. Epub 2012 Nov 9.

12.

Her2/neu small interfering RNA delivered in culture by a streptavidin nanoparticle.

Liu X, Nakamura K, Cheng D, Peng C, Xiao N, Liu Y, Chen L, Rusckowski M, Hnatowich DJ.

Curr Drug Deliv. 2012 Jul;9(4):431-6.

PMID:
22520071
13.

Radiolabeled Zn-DPA as a potential infection imaging agent.

Liu X, Cheng D, Gray BD, Wang Y, Akalin A, Rusckowski M, Pak KY, Hnatowich DJ.

Nucl Med Biol. 2012 Jul;39(5):709-14. doi: 10.1016/j.nucmedbio.2011.12.006. Epub 2012 Feb 10.

PMID:
22321532
14.

Pretargeting vs. direct targeting of human betalox5 islet cells subcutaneously implanted in mice using an anti-human islet cell antibody.

Liu G, Dou S, Akalin A, Rusckowski M, Streeter PR, Shultz LD, Greiner DL.

Nucl Med Biol. 2012 Jul;39(5):645-51. doi: 10.1016/j.nucmedbio.2011.12.001. Epub 2012 Feb 10.

15.

Activin-like kinase 3 is important for kidney regeneration and reversal of fibrosis.

Sugimoto H, LeBleu VS, Bosukonda D, Keck P, Taduri G, Bechtel W, Okada H, Carlson W Jr, Bey P, Rusckowski M, Tampe B, Tampe D, Kanasaki K, Zeisberg M, Kalluri R.

Nat Med. 2012 Feb 5;18(3):396-404. doi: 10.1038/nm.2629.

16.

A brief evaluation of tumor imaging in mice with 99mTc-glucarate including a comparison with 18F-FDG.

Cheng D, Rusckowski M, Wang Y, Liu Y, Liu G, Liu X, Hnatowich D.

Curr Radiopharm. 2011 Jan;4(1):5-9.

PMID:
22191610
17.

90Y labeled phosphorodiamidate morpholino oligomer for pretargeting radiotherapy.

Liu G, Dou S, Liu Y, Wang Y, Rusckowski M, Hnatowich DJ.

Bioconjug Chem. 2011 Dec 21;22(12):2539-45. doi: 10.1021/bc200366t. Epub 2011 Nov 3.

18.

Comparing the intracellular fate of components within a noncovalent streptavidin nanoparticle with covalent conjugation.

Liu Y, Cheng D, Liu X, Liu G, Dou S, Xiao N, Chen L, Rusckowski M, Hnatowich DJ.

Nucl Med Biol. 2012 Jan;39(1):101-7. doi: 10.1016/j.nucmedbio.2011.06.006. Epub 2011 Sep 29.

PMID:
21958854
19.

Comparing two TAG-72 binding peptides previously identified by phage display as potential imaging agents.

Chen L, Wang Y, Cheng D, Dou S, Liu X, Liu G, Hnatowich DJ, Rusckowski M.

Nucl Med Commun. 2011 Oct;32(10):920-4. doi: 10.1097/MNM.0b013e328348fc64.

20.

Improving the quantitation accuracy in noninvasive small animal single photon emission computed tomography imaging.

Cheng D, Rusckowski M, Pretorius PH, Chen L, Xiao N, Liu Y, Liu G, Liang M, Liu X, Dou S, Hnatowich DJ.

Nucl Med Biol. 2011 Aug;38(6):843-8. doi: 10.1016/j.nucmedbio.2011.02.004. Epub 2011 Apr 21.

PMID:
21843780
21.

Human islet cell MORF/cMORF pretargeting in a xenogeneic murine transplant model.

Liu G, Dou S, Cheng D, Leif J, Rusckowski M, Streeter PR, Shultz LD, Hnatowich DJ, Greiner DL.

Mol Pharm. 2011 Jun 6;8(3):767-73. doi: 10.1021/mp100382m. Epub 2011 Apr 21.

22.

Assessing antibody pharmacokinetics in mice with in vivo imaging.

Hoppin J, Orcutt KD, Hesterman JY, Silva MD, Cheng D, Lackas C, Rusckowski M.

J Pharmacol Exp Ther. 2011 May;337(2):350-8. doi: 10.1124/jpet.110.172916. Epub 2011 Feb 11. Review.

PMID:
21317355
23.

Unexpected side products in the conjugation of an amine-derivatized morpholino oligomer with p-isothiocyanate benzyl DTPA and their removal.

Liu G, Dou S, Liu Y, Liang M, Chen L, Cheng D, Greiner D, Rusckowski M, Hnatowich DJ.

Nucl Med Biol. 2011 Feb;38(2):159-63. doi: 10.1016/j.nucmedbio.2010.08.008. Epub 2010 Oct 27.

24.

Adding a clearing agent to pretargeting does not lower the tumor accumulation of the effector as predicted.

Liu G, Dou S, Chen X, Chen L, Liu X, Rusckowski M, Hnatowich DJ.

Cancer Biother Radiopharm. 2010 Dec;25(6):757-62. doi: 10.1089/cbr.2010.0800.

25.

Reducing the background fluorescence in mice receiving fluorophore/inhibitor DNA duplexes.

Liang M, Liu X, Liu G, Dou S, Cheng D, Liu Y, Rusckowski M, Hnatowich DJ.

Mol Pharm. 2011 Feb 7;8(1):126-32. doi: 10.1021/mp100229z. Epub 2010 Dec 22.

PMID:
21133414
26.

A preclinical 188Re tumor therapeutic investigation using MORF/cMORF pretargeting and an antiTAG-72 antibody CC49.

Liu G, Dou S, Baker S, Akalin A, Cheng D, Chen L, Rusckowski M, Hnatowich DJ.

Cancer Biol Ther. 2010 Oct 15;10(8):767-74. doi: 10.4161/cbt.10.8.12879.

27.

Identification of a high affinity TAG-72 binding peptide by phage display selection.

Xiao N, Cheng D, Wang Y, Chen L, Liu X, Dou S, Liu G, Liang M, Hnatowich DJ, Rusckowski M.

Cancer Biol Ther. 2011 Jan 1;11(1):22-31. Epub 2011 Jan 1.

28.

Auger-mediated cytotoxicity of cancer cells in culture by an 125I-antisense oligomer delivered as a three-component streptavidin nanoparticle.

Liu X, Nakamura K, Wang Y, Cheng D, Liang M, Xiao N, Chen L, Rusckowski M, Hnatowich DJ.

J Biomed Nanotechnol. 2010 Apr;6(2):153-7.

PMID:
20738069
29.

Comparison of 18F PET and 99mTc SPECT imaging in phantoms and in tumored mice.

Cheng D, Wang Y, Liu X, Pretorius PH, Liang M, Rusckowski M, Hnatowich DJ.

Bioconjug Chem. 2010 Aug 18;21(8):1565-70. doi: 10.1021/bc1001467.

30.

Tumor pretargeting in mice using MORF conjugated CC49 antibody and radiolabeled complimentary cMORF effector.

Liu G, Dou S, Pretorius PH, Liu X, Chen L, Rusckowski M, Hnatowich DJ.

Q J Nucl Med Mol Imaging. 2010 Jun;54(3):333-40. Epub 2009 Dec 15.

31.

Multimodality nuclear and fluorescence tumor imaging in mice using a streptavidin nanoparticle.

Liang M, Liu X, Cheng D, Liu G, Dou S, Wang Y, Rusckowski M, Hnatowich DJ.

Bioconjug Chem. 2010 Jul 21;21(7):1385-8. doi: 10.1021/bc100081h.

PMID:
20557066
32.

Preparation of (111)In-DTPA morpholino oligomer for low abdominal accumulation.

Liu G, Dou S, Rusckowski M, Greiner D, Hnatowich D.

Appl Radiat Isot. 2010 Sep;68(9):1709-14. doi: 10.1016/j.apradiso.2010.03.002. Epub 2010 Mar 6.

33.

In vivo delivery of antisense MORF oligomer by MORF/carrier streptavidin nanoparticles.

Wang Y, Liu X, Nakamura K, Chen L, Rusckowski M, Hnatowich DJ.

Cancer Biother Radiopharm. 2009 Oct;24(5):573-8. doi: 10.1089/cbr.2009.0624.

34.

The ratio of maximum percent tumour accumulations of the pretargeting agent and the radiolabelled effector is independent of tumour size.

Liu G, Dou S, Liang M, Chen X, Rusckowski M, Hnatowich DJ.

Eur J Cancer. 2009 Nov;45(17):3098-103. doi: 10.1016/j.ejca.2009.09.007. Epub 2009 Oct 5.

35.

Tumor delivery of antisense oligomer using trastuzumab within a streptavidin nanoparticle.

Wang Y, Liu X, Chen L, Cheng D, Rusckowski M, Hnatowich DJ.

Eur J Nucl Med Mol Imaging. 2009 Dec;36(12):1977-86. doi: 10.1007/s00259-009-1201-2.

PMID:
19572130
36.

Optical antisense tumor targeting in vivo with an improved fluorescent DNA duplex probe.

Liang M, Liu X, Cheng D, Nakamura K, Wang Y, Dou S, Liu G, Rusckowski M, Hnatowich DJ.

Bioconjug Chem. 2009 Jun;20(6):1223-7. doi: 10.1021/bc9000933.

37.

A convenient thiazole orange fluorescence assay for the evaluation of DNA duplex hybridization stability.

Liang M, Liu X, Nakamura K, Chen X, Cheng D, Liu G, Dou S, Wang Y, Rusckowski M, Hnatowich DJ.

Mol Imaging Biol. 2009 Nov-Dec;11(6):439-45. doi: 10.1007/s11307-009-0221-4. Epub 2009 May 15.

38.

Replacing 99mTc with 111In improves MORF/cMORF pretargeting by reducing intestinal accumulation.

Liu G, Cheng D, Dou S, Chen X, Liang M, Pretorius PH, Rusckowski M, Hnatowich DJ.

Mol Imaging Biol. 2009 Sep-Oct;11(5):303-7. doi: 10.1007/s11307-009-0209-0. Epub 2009 Mar 27.

39.

Auger radiation-induced, antisense-mediated cytotoxicity of tumor cells using a 3-component streptavidin-delivery nanoparticle with 111In.

Liu X, Wang Y, Nakamura K, Kawauchi S, Akalin A, Cheng D, Chen L, Rusckowski M, Hnatowich DJ.

J Nucl Med. 2009 Apr;50(4):582-90. doi: 10.2967/jnumed.108.056366. Epub 2009 Mar 16.

40.

A new TAG-72 cancer marker peptide identified by phage display.

Chen L, Wang Y, Liu X, Dou S, Liu G, Hnatowich DJ, Rusckowski M.

Cancer Lett. 2008 Dec 8;272(1):122-32. doi: 10.1016/j.canlet.2008.07.009. Epub 2008 Aug 23.

41.

Synthesis and in vitro characterization of a dendrimer-MORF conjugate for amplification pretargeting.

Chen X, Dou S, Liu G, Liu X, Wang Y, Chen L, Rusckowski M, Hnatowich DJ.

Bioconjug Chem. 2008 Aug;19(8):1518-25. doi: 10.1021/bc8001024. Epub 2008 Jul 23.

42.

An experimental and theoretical evaluation of the influence of pretargeting antibody on the tumor accumulation of effector.

Liu G, Dou S, Rusckowski M, Hnatowich DJ.

Mol Cancer Ther. 2008 May;7(5):1025-32. doi: 10.1158/1535-7163.MCT-07-2203.

43.

Investigation of four (99m)Tc-labeled bacteriophages for infection-specific imaging.

Rusckowski M, Gupta S, Liu G, Dou S, Hnatowich DJ.

Nucl Med Biol. 2008 May;35(4):433-40. doi: 10.1016/j.nucmedbio.2008.02.011.

44.

Evaluation of technetium Tc 99m-labeled biotin for scintigraphic detection of soft tissue inflammation in horses.

Kleine LG, Solano M, Rusckowski M, Hunt KE, Johnson KL, Kirker-Head CA.

Am J Vet Res. 2008 May;69(5):639-46. doi: 10.2460/ajvr.69.5.639.

PMID:
18447795
45.

Optical antisense imaging of tumor with fluorescent DNA duplexes.

Liu X, Wang Y, Nakamura K, Liu G, Dou S, Kubo A, Rusckowski M, Hnatowich DJ.

Bioconjug Chem. 2007 Nov-Dec;18(6):1905-11. Epub 2007 Oct 17.

PMID:
17939728
46.

Pretargeting CWR22 prostate tumor in mice with MORF-B72.3 antibody and radiolabeled cMORF.

Liu G, Dou S, Pretorius PH, Liu X, Rusckowski M, Hnatowich DJ.

Eur J Nucl Med Mol Imaging. 2008 Feb;35(2):272-80. Epub 2007 Oct 2.

47.

Evidence of specificity of radiolabeled phage display peptides for the TAG-72 antigen.

Rusckowski M, Gupta S, Liu G, Dou S, Hnatowich DJ.

Cancer Biother Radiopharm. 2007 Aug;22(4):564-72.

PMID:
17803452
48.

Comparison of several linear fluorophore- and quencher-conjugated oligomer duplexes for stability, fluorescence quenching, and kinetics in vitro and in vivo in mice.

Zhang S, Liu G, Liu X, Yin D, Dou S, He J, Rusckowski M, Hnatowich DJ.

Bioconjug Chem. 2007 Jul-Aug;18(4):1170-5. Epub 2007 May 19.

49.

A novel pretargeting method for measuring antibody internalization in tumor cells.

Liu G, Dou S, Yin D, Squires S, Liu X, Wang Y, Rusckowski M, Hnatowich DJ.

Cancer Biother Radiopharm. 2007 Feb;22(1):33-9.

50.

An improved method for covalently conjugating morpholino oligomers to antitumor antibodies.

He J, Liu G, Dou S, Gupta S, Rusckowski M, Hnatowich D.

Bioconjug Chem. 2007 May-Jun;18(3):983-8. Epub 2007 Mar 27.

Supplemental Content

Loading ...
Support Center